Chapter/Section Purchase

1 Study Coverage
1.1 Proto-Oncogene Drgu Product Introduction
1.2 Market by Type
1.2.1 Global Proto-Oncogene Drgu Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Axitinib (Inlyta)
1.2.3 Ponatinib (Iclusig)
1.2.4 Imatinib (Gleevec)
1.2.5 Sunitinib (Sutent)
1.2.6 Pazopanib (Votrient)
1.2.7 Dabrafenib (Tafinlar)
1.2.8 Vandetanib (Caprelsa)
1.2.9 Vemurafenib (Zelboraf)
1.2.10 Cabozantinib (Cabometyx and Cometriq)
1.2.11 Sorafenib (Nexavar)
1.3 Market by Application
1.3.1 Global Proto-Oncogene Drgu Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Proto-Oncogene Drgu Sales Estimates and Forecasts 2017-2028
2.2 Global Proto-Oncogene Drgu Revenue Estimates and Forecasts 2017-2028
2.3 Global Proto-Oncogene Drgu Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Proto-Oncogene Drgu Sales by Region
2.4.1 Global Proto-Oncogene Drgu Sales by Region (2017-2022)
2.4.2 Global Sales Proto-Oncogene Drgu by Region (2023-2028)
2.5 Global Proto-Oncogene Drgu Revenue by Region
2.5.1 Global Proto-Oncogene Drgu Revenue by Region (2017-2022)
2.5.2 Global Proto-Oncogene Drgu Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Proto-Oncogene Drgu Sales by Manufacturers
3.1.1 Global Top Proto-Oncogene Drgu Manufacturers by Sales (2017-2022)
3.1.2 Global Proto-Oncogene Drgu Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Proto-Oncogene Drgu in 2021
3.2 Global Proto-Oncogene Drgu Revenue by Manufacturers
3.2.1 Global Proto-Oncogene Drgu Revenue by Manufacturers (2017-2022)
3.2.2 Global Proto-Oncogene Drgu Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Proto-Oncogene Drgu Revenue in 2021
3.3 Global Proto-Oncogene Drgu Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Proto-Oncogene Drgu Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Proto-Oncogene Drgu Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Proto-Oncogene Drgu Sales by Type
4.1.1 Global Proto-Oncogene Drgu Historical Sales by Type (2017-2022)
4.1.2 Global Proto-Oncogene Drgu Forecasted Sales by Type (2023-2028)
4.1.3 Global Proto-Oncogene Drgu Sales Market Share by Type (2017-2028)
4.2 Global Proto-Oncogene Drgu Revenue by Type
4.2.1 Global Proto-Oncogene Drgu Historical Revenue by Type (2017-2022)
4.2.2 Global Proto-Oncogene Drgu Forecasted Revenue by Type (2023-2028)
4.2.3 Global Proto-Oncogene Drgu Revenue Market Share by Type (2017-2028)
4.3 Global Proto-Oncogene Drgu Price by Type
4.3.1 Global Proto-Oncogene Drgu Price by Type (2017-2022)
4.3.2 Global Proto-Oncogene Drgu Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Proto-Oncogene Drgu Sales by Application
5.1.1 Global Proto-Oncogene Drgu Historical Sales by Application (2017-2022)
5.1.2 Global Proto-Oncogene Drgu Forecasted Sales by Application (2023-2028)
5.1.3 Global Proto-Oncogene Drgu Sales Market Share by Application (2017-2028)
5.2 Global Proto-Oncogene Drgu Revenue by Application
5.2.1 Global Proto-Oncogene Drgu Historical Revenue by Application (2017-2022)
5.2.2 Global Proto-Oncogene Drgu Forecasted Revenue by Application (2023-2028)
5.2.3 Global Proto-Oncogene Drgu Revenue Market Share by Application (2017-2028)
5.3 Global Proto-Oncogene Drgu Price by Application
5.3.1 Global Proto-Oncogene Drgu Price by Application (2017-2022)
5.3.2 Global Proto-Oncogene Drgu Price Forecast by Application (2023-2028)
6 North America
6.1 North America Proto-Oncogene Drgu Market Size by Type
6.1.1 North America Proto-Oncogene Drgu Sales by Type (2017-2028)
6.1.2 North America Proto-Oncogene Drgu Revenue by Type (2017-2028)
6.2 North America Proto-Oncogene Drgu Market Size by Application
6.2.1 North America Proto-Oncogene Drgu Sales by Application (2017-2028)
6.2.2 North America Proto-Oncogene Drgu Revenue by Application (2017-2028)
6.3 North America Proto-Oncogene Drgu Market Size by Country
6.3.1 North America Proto-Oncogene Drgu Sales by Country (2017-2028)
6.3.2 North America Proto-Oncogene Drgu Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Proto-Oncogene Drgu Market Size by Type
7.1.1 Europe Proto-Oncogene Drgu Sales by Type (2017-2028)
7.1.2 Europe Proto-Oncogene Drgu Revenue by Type (2017-2028)
7.2 Europe Proto-Oncogene Drgu Market Size by Application
7.2.1 Europe Proto-Oncogene Drgu Sales by Application (2017-2028)
7.2.2 Europe Proto-Oncogene Drgu Revenue by Application (2017-2028)
7.3 Europe Proto-Oncogene Drgu Market Size by Country
7.3.1 Europe Proto-Oncogene Drgu Sales by Country (2017-2028)
7.3.2 Europe Proto-Oncogene Drgu Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Proto-Oncogene Drgu Market Size by Type
8.1.1 Asia Pacific Proto-Oncogene Drgu Sales by Type (2017-2028)
8.1.2 Asia Pacific Proto-Oncogene Drgu Revenue by Type (2017-2028)
8.2 Asia Pacific Proto-Oncogene Drgu Market Size by Application
8.2.1 Asia Pacific Proto-Oncogene Drgu Sales by Application (2017-2028)
8.2.2 Asia Pacific Proto-Oncogene Drgu Revenue by Application (2017-2028)
8.3 Asia Pacific Proto-Oncogene Drgu Market Size by Region
8.3.1 Asia Pacific Proto-Oncogene Drgu Sales by Region (2017-2028)
8.3.2 Asia Pacific Proto-Oncogene Drgu Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Proto-Oncogene Drgu Market Size by Type
9.1.1 Latin America Proto-Oncogene Drgu Sales by Type (2017-2028)
9.1.2 Latin America Proto-Oncogene Drgu Revenue by Type (2017-2028)
9.2 Latin America Proto-Oncogene Drgu Market Size by Application
9.2.1 Latin America Proto-Oncogene Drgu Sales by Application (2017-2028)
9.2.2 Latin America Proto-Oncogene Drgu Revenue by Application (2017-2028)
9.3 Latin America Proto-Oncogene Drgu Market Size by Country
9.3.1 Latin America Proto-Oncogene Drgu Sales by Country (2017-2028)
9.3.2 Latin America Proto-Oncogene Drgu Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Proto-Oncogene Drgu Market Size by Type
10.1.1 Middle East and Africa Proto-Oncogene Drgu Sales by Type (2017-2028)
10.1.2 Middle East and Africa Proto-Oncogene Drgu Revenue by Type (2017-2028)
10.2 Middle East and Africa Proto-Oncogene Drgu Market Size by Application
10.2.1 Middle East and Africa Proto-Oncogene Drgu Sales by Application (2017-2028)
10.2.2 Middle East and Africa Proto-Oncogene Drgu Revenue by Application (2017-2028)
10.3 Middle East and Africa Proto-Oncogene Drgu Market Size by Country
10.3.1 Middle East and Africa Proto-Oncogene Drgu Sales by Country (2017-2028)
10.3.2 Middle East and Africa Proto-Oncogene Drgu Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ARIAD Pharmaceuticals
11.1.1 ARIAD Pharmaceuticals Corporation Information
11.1.2 ARIAD Pharmaceuticals Overview
11.1.3 ARIAD Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ARIAD Pharmaceuticals Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ARIAD Pharmaceuticals Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Bayer Healthcare
11.3.1 Bayer Healthcare Corporation Information
11.3.2 Bayer Healthcare Overview
11.3.3 Bayer Healthcare Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Healthcare Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Healthcare Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Overview
11.4.3 Bristol-Myers Squibb Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bristol-Myers Squibb Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 ChemGenex Pharmaceuticals
11.5.1 ChemGenex Pharmaceuticals Corporation Information
11.5.2 ChemGenex Pharmaceuticals Overview
11.5.3 ChemGenex Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 ChemGenex Pharmaceuticals Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 ChemGenex Pharmaceuticals Recent Developments
11.6 Dexa Medica
11.6.1 Dexa Medica Corporation Information
11.6.2 Dexa Medica Overview
11.6.3 Dexa Medica Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Dexa Medica Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dexa Medica Recent Developments
11.7 Eisai Pharmaceuticals
11.7.1 Eisai Pharmaceuticals Corporation Information
11.7.2 Eisai Pharmaceuticals Overview
11.7.3 Eisai Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eisai Pharmaceuticals Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eisai Pharmaceuticals Recent Developments
11.8 Exelixis
11.8.1 Exelixis Corporation Information
11.8.2 Exelixis Overview
11.8.3 Exelixis Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Exelixis Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Exelixis Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Overview
11.9.3 GlaxoSmithKline Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 GlaxoSmithKline Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Onyx Pharmaceuticals
11.11.1 Onyx Pharmaceuticals Corporation Information
11.11.2 Onyx Pharmaceuticals Overview
11.11.3 Onyx Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Onyx Pharmaceuticals Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Onyx Pharmaceuticals Recent Developments
11.12 Plexxikon
11.12.1 Plexxikon Corporation Information
11.12.2 Plexxikon Overview
11.12.3 Plexxikon Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Plexxikon Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Plexxikon Recent Developments
11.13 Pfizer
11.13.1 Pfizer Corporation Information
11.13.2 Pfizer Overview
11.13.3 Pfizer Proto-Oncogene Drgu Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pfizer Proto-Oncogene Drgu Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Proto-Oncogene Drgu Industry Chain Analysis
12.2 Proto-Oncogene Drgu Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Proto-Oncogene Drgu Production Mode & Process
12.4 Proto-Oncogene Drgu Sales and Marketing
12.4.1 Proto-Oncogene Drgu Sales Channels
12.4.2 Proto-Oncogene Drgu Distributors
12.5 Proto-Oncogene Drgu Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Proto-Oncogene Drgu Industry Trends
13.2 Proto-Oncogene Drgu Market Drivers
13.3 Proto-Oncogene Drgu Market Challenges
13.4 Proto-Oncogene Drgu Market Restraints
14 Key Findings in The Global Proto-Oncogene Drgu Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer